Eurizon Capital SGR S.p.A. Makes New $76.58 Million Investment in Danaher Corporation $DHR

Eurizon Capital SGR S.p.A. acquired a new position in shares of Danaher Corporation (NYSE:DHR) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 334,438 shares of the conglomerate’s stock, valued at approximately $76,582,000.

Other institutional investors have also recently bought and sold shares of the company. Elevated Capital Advisors LLC purchased a new stake in shares of Danaher during the 4th quarter worth about $26,000. JPL Wealth Management LLC purchased a new stake in shares of Danaher during the 3rd quarter worth about $25,000. WFA of San Diego LLC purchased a new stake in shares of Danaher during the 2nd quarter worth about $26,000. ANTIPODES PARTNERS Ltd purchased a new stake in shares of Danaher during the 3rd quarter worth about $27,000. Finally, MidAtlantic Capital Management Inc. purchased a new stake in shares of Danaher during the 4th quarter worth about $33,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Up 1.2%

Shares of DHR stock opened at $182.73 on Friday. The stock’s 50 day simple moving average is $182.11 and its 200 day simple moving average is $207.48. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a market capitalization of $129.33 billion, a price-to-earnings ratio of 35.34, a PEG ratio of 2.41 and a beta of 0.81.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. During the same period last year, the business earned $1.88 EPS. The firm’s revenue was up 3.7% compared to the same quarter last year. As a group, research analysts predict that Danaher Corporation will post 8.43 EPS for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is presently 30.95%.

Analyst Ratings Changes

A number of research firms have recently weighed in on DHR. Barclays cut their price target on Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Rothschild & Co Redburn set a $205.00 price target on Danaher in a research note on Friday, April 17th. The Goldman Sachs Group cut their price target on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research note on Monday, April 13th. JPMorgan Chase & Co. cut their price target on Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. Finally, Citigroup began coverage on Danaher in a research note on Tuesday. They set a “buy” rating and a $230.00 price target for the company. Twenty research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $238.24.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.